Susquehanna International Group’s Tourmaline Bio TRML Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
-60,649
| Closed | -$2.9M | – | 13643 |
|
|
2025
Q3 | $2.9M | Buy |
60,649
+28,576
| +89% | +$793K | ﹤0.01% | 5040 |
|
|
2025
Q2 | $513K | Sell |
32,073
-16,511
| -34% | -$268K | ﹤0.01% | 9126 |
|
|
2025
Q1 | $739K | Buy |
48,584
+35,077
| +260% | +$562K | ﹤0.01% | 8014 |
|
|
2024
Q4 | $274K | Buy |
13,507
+2,546
| +23% | +$64.1K | ﹤0.01% | 10030 |
|
|
2024
Q3 | $282K | Sell |
10,961
-30,243
| -73% | -$505K | ﹤0.01% | 9734 |
|
|
2024
Q2 | $530K | Sell |
41,204
-48,681
| -54% | -$783K | ﹤0.01% | 8138 |
|
|
2024
Q1 | $2.06M | Buy |
89,885
+73,013
| +433% | +$2.57M | ﹤0.01% | 5266 |
|
|
2023
Q4 | $442K | Buy |
16,872
+15,030
| +816% | +$301K | ﹤0.01% | 8972 |
|
|
2023
Q3 | $51.8K | Sell |
1,842
-1,363
| -43% | -$39.9K | ﹤0.01% | 11289 |
|
|
2023
Q2 | $97.4K | Buy |
3,205
+1,765
| +123% | +$45.1K | ﹤0.01% | 10966 |
|
|
2023
Q1 | $27.1K | Buy |
+1,440
| New | +$23.8K | ﹤0.01% | 11956 |
|
|
2022
Q2 | – | Sell |
-1,721
| Closed | -$169K | – | 13964 |
|
|
2022
Q1 | $169K | Buy |
+1,721
| New | +$161K | ﹤0.01% | 11442 |
|
Susquehanna International Group's TRML Position: Q4 2025 in Review
Susquehanna International Group sold out of Tourmaline Bio (TRML) in Q4 2025, closing a stake of 60,649 shares — an estimated $2.9M sold.
Susquehanna International Group first reported a position in TRML in Q1 2022 and held it in 12 quarters. The position peaked at $2.9M in Q3 2025. 0 funds tracked by Wall St. Rank hold TRML as of Q4 2025.
- Susquehanna International Group reported no remaining Tourmaline Bio position as of Q4 2025 after selling out during the quarter.
- Susquehanna International Group sold 60,649 Tourmaline Bio shares in Q4 2025, an estimated $2.9M.
- Susquehanna International Group first reported a position in Tourmaline Bio in Q1 2022 and held it in 12 quarters.
- Susquehanna International Group's Tourmaline Bio position peaked at $2.9M in Q3 2025.
- 0 funds tracked by Wall St. Rank held Tourmaline Bio as of Q4 2025.
Based on Susquehanna International Group's 13F filing for Q4 2025, filed 17 Feb 2026.